BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35488417)

  • 1. Cervical intraepithelial neoplasia in women with transformation zone type 3: cervical biopsy versus large loop excision.
    Gustafson LW; Hammer A; Bennetsen MH; Kristensen CB; Majeed H; Petersen LK; Andersen B; Bor P
    BJOG; 2022 Dec; 129(13):2132-2140. PubMed ID: 35488417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of cervical intraepithelial neoplasia grade 2 or worse in women aged ≥ 69 referred to colposcopy due to an HPV-positive screening test.
    Booth BB; Tranberg M; Gustafson LW; Christiansen AG; Lapirtis H; Krogh LM; Hjorth IMD; Hammer A
    BMC Cancer; 2023 May; 23(1):405. PubMed ID: 37142959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of p16/Ki67 dual-stain cytology for detection of cervical intraepithelial neoplasia grade two or worse in women with a transformation zone type 3: A cross-sectional study.
    Gustafson LW; Tranberg M; Christensen PN; Brøndum R; Wentzensen N; Clarke MA; Andersen B; Petersen LK; Bor P; Hammer A
    BJOG; 2023 Jan; 130(2):202-209. PubMed ID: 35686564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small lesion size measured by colposcopy may predict absence of cervical intraepithelial neoplasia in a large loop excision of the transformation zone specimen.
    Munmany M; Marimon L; Cardona M; Nonell R; Juiz M; Astudillo R; Ordi J; Torné A; Del Pino M
    BJOG; 2017 Feb; 124(3):495-502. PubMed ID: 27506510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follow-up strategies after treatment (large loop excision of the transformation zone (LLETZ)) for cervical intraepithelial neoplasia (CIN): Impact of human papillomavirus (HPV) test.
    van der Heijden E; Lopes AD; Bryant A; Bekkers R; Galaal K
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010757. PubMed ID: 25562623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial.
    TOMBOLA Group
    BMJ; 2009 Jul; 339():b2548. PubMed ID: 19638647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of HPV cervical screening on negative large loop excision of the transformation zone (LLETZ): A comparative cohort study.
    Manley KM; Wills AK; Morris GC; Hogg JL; López Bernal A; Murdoch JB
    Gynecol Oncol; 2016 Jun; 141(3):485-491. PubMed ID: 27032376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indication and outcome of repeat large loop excision biopsies of the cervix.
    Moss EL; Appleyard TL; Winning JM; Jones PW; Luesley DM
    J Low Genit Tract Dis; 2011 Apr; 15(2):89-92. PubMed ID: 21169867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does colposcopically directed punch biopsy reduce the incidence of negative LLETZ?
    Denny LA; Soeters R; Dehaeck K; Bloch B
    Br J Obstet Gynaecol; 1995 Jul; 102(7):545-8. PubMed ID: 7647056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cure rates in women treated with cold-coagulation versus LLETZ cervical treatment for CIN2-3 on pretreatment cervical punch biopsies: a retrospective cohort study.
    Papoutsis D; Underwood M; Parry-Smith W; Panikkar J
    Arch Gynecol Obstet; 2017 Apr; 295(4):979-986. PubMed ID: 28229232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of human papillomavirus testing in the management of women with low-grade abnormalities: multicentre randomised controlled trial.
    Cotton S; Sharp L; Little J; Cruickshank M; Seth R; Smart L; Duncan I; Harrild K; Neal K; Waugh N;
    BJOG; 2010 May; 117(6):645-59. PubMed ID: 20374607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The increased detection of cervical intraepithelial neoplasia when using a second biopsy at colposcopy.
    van der Marel J; van Baars R; Rodriguez A; Quint WG; van de Sandt MM; Berkhof J; Schiffman M; Torné A; Ordi J; Jenkins D; Verheijen RH; Helmerhorst TJ; Ter Harmsel B; Wentzensen N; Del Pino M
    Gynecol Oncol; 2014 Nov; 135(2):201-7. PubMed ID: 25204846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How can the incidence of negative specimens resulting from large loop excision of the cervical transformation zone (LLETZ) be reduced? An analysis of negative LLETZ specimens and development of a predictive model.
    Howells RE; O'Mahony F; Tucker H; Millinship J; Jones PW; Redman CW
    BJOG; 2000 Sep; 107(9):1075-82. PubMed ID: 11002948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overtreatment rate after immediate local excision of suspected cervical intraepithelial neoplasia: A prospective cohort study.
    Kiviharju M; Heinonen A; Jakobsson M; Virtanen S; Auvinen E; Kotaniemi-Talonen L; Dillner J; Kyrgiou M; Nieminen P; Aro K; Kalliala I
    Gynecol Oncol; 2022 Nov; 167(2):167-173. PubMed ID: 36153296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screen-and-treat approach in managing cervical cancer precursor lesions: An observational study with 524 women.
    Yoneda JY; Teixeira JC; Derchain S; Bragança JF; Zeferino LC; Vale DB
    Eur J Obstet Gynecol Reprod Biol; 2023 Jan; 280():78-82. PubMed ID: 36434824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does LLETZ excision margin status predict residual disease in women who have undergone post-treatment cervical cytology and high-risk human papillomavirus testing?
    Palmer JE; Ravenscroft S; Ellis K; Crossley J; Dudding N; Smith JH; Tidy JA
    Cytopathology; 2016 Jun; 27(3):210-7. PubMed ID: 26415635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of human papillomavirus genotype on colposcopic appearance: a cross-sectional analysis.
    van der Marel J; van Baars R; Quint WG; Berkhof J; del Pino M; Torné A; Ordi J; Wentzensen N; Schiffman M; van de Sandt MM; Lindeman J; Jenkins D; Helmerhorst TJ; Verheijen RH; ter Harmsel B; Alonso I
    BJOG; 2014 Aug; 121(9):1117-26. PubMed ID: 24494663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The volume perspective: a comparison of two excisional treatments for cervical intraepithelial neoplasia (laser versus LLETZ).
    Phadnis SV; Atilade A; Young MP; Evans H; Walker PG
    BJOG; 2010 Apr; 117(5):615-9. PubMed ID: 20156211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.